propranolol has been researched along with Cardiac Arrest, Sudden in 26 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study evaluated the effects of propranolol on recovery of heart rate variability (HRV) after acute myocardial infarction and its relation to outcome in the Beta-blocker Heart Attack Trial (BHAT)." | 9.10 | Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial. ( Horwitz, RI; Ickovics, JR; Lampert, R; Lee, FA; Viscoli, CJ, 2003) |
| "In the test with saline solution, 100% of the dogs developed ventricular fibrillation; this occurred in only 10% of the tests with propranolol (95% confidence interval 0." | 7.68 | Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. ( De Ferrari, GM; Grossoni, M; Patrono, C; Salvati, P; Schwartz, PJ; Ukmar, G; Vaga, L, 1993) |
| "This study evaluated the effects of propranolol on recovery of heart rate variability (HRV) after acute myocardial infarction and its relation to outcome in the Beta-blocker Heart Attack Trial (BHAT)." | 5.10 | Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial. ( Horwitz, RI; Ickovics, JR; Lampert, R; Lee, FA; Viscoli, CJ, 2003) |
| "A 35-year-old black woman with a history of bronchial asthma collapsed and died after ingestion of three 20-mg tablets of propranolol." | 3.72 | An unusual death in an asthmatic patient. ( Spitz, DJ, 2003) |
| "In the test with saline solution, 100% of the dogs developed ventricular fibrillation; this occurred in only 10% of the tests with propranolol (95% confidence interval 0." | 3.68 | Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. ( De Ferrari, GM; Grossoni, M; Patrono, C; Salvati, P; Schwartz, PJ; Ukmar, G; Vaga, L, 1993) |
| "Most studies of the timing of onset of sudden cardiac death have revealed a prominent midmorning peak, thought to be related to a surge in catecholamines associated with arising and assuming the upright posture, that is blunted or eliminated by beta blockers." | 2.39 | Circadian patterns and triggers of sudden cardiac death. ( Peters, RW, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (42.31) | 18.2507 |
| 2000's | 7 (26.92) | 29.6817 |
| 2010's | 8 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tofler, GH | 1 |
| Spinaze, M | 1 |
| Shaw, E | 1 |
| Buckley, T | 1 |
| Calvillo, L | 1 |
| Spazzolini, C | 1 |
| Vullo, E | 1 |
| Insolia, R | 1 |
| Crotti, L | 2 |
| Schwartz, PJ | 6 |
| Fabritz, L | 1 |
| Franz, MR | 1 |
| Carmeliet, E | 1 |
| Kirchhof, P | 1 |
| Abu-Zeitone, A | 1 |
| Peterson, DR | 1 |
| Polonsky, B | 1 |
| McNitt, S | 1 |
| Moss, AJ | 1 |
| Wang, H | 1 |
| Tang, W | 1 |
| Ristagno, G | 1 |
| Li, Y | 1 |
| Sun, S | 1 |
| Wang, T | 1 |
| Weil, MH | 1 |
| McMurray, JJ | 1 |
| Gemma, LW | 1 |
| Ward, GM | 1 |
| Dettmer, MM | 1 |
| Ball, JL | 1 |
| Leo, PJ | 1 |
| Doria, DN | 1 |
| Kaufman, ES | 1 |
| Lampert, R | 1 |
| Ickovics, JR | 1 |
| Viscoli, CJ | 1 |
| Horwitz, RI | 1 |
| Lee, FA | 1 |
| Adamson, PB | 1 |
| Vanoli, E | 2 |
| Shibano, T | 1 |
| Foreman, RD | 2 |
| Spitz, DJ | 1 |
| Kriebel, T | 1 |
| Korte, T | 1 |
| Kandolf, R | 1 |
| Jux, C | 1 |
| Windhagen-Mahnert, B | 1 |
| Bökenkamp, R | 1 |
| Bertram, H | 1 |
| Paul, T | 1 |
| Aouate, P | 1 |
| Clerc, J | 1 |
| Viard, P | 1 |
| Seoud, J | 1 |
| Wang, JF | 1 |
| Meissner, A | 1 |
| Malek, S | 1 |
| Chen, Y | 1 |
| Ke, Q | 1 |
| Zhang, J | 1 |
| Chu, V | 1 |
| Hampton, TG | 1 |
| Crumpacker, CS | 1 |
| Abelmann, WH | 1 |
| Amende, I | 1 |
| Morgan, JP | 1 |
| Aronow, WS | 3 |
| Ahn, C | 3 |
| Mercando, AD | 3 |
| Epstein, S | 3 |
| Kronzon, I | 1 |
| Hull, SS | 1 |
| Ferrari, A | 1 |
| McCurdy, CM | 1 |
| Rutherford, SE | 1 |
| Coddington, CC | 1 |
| Garson, A | 1 |
| Dick, M | 1 |
| Fournier, A | 1 |
| Gillette, PC | 1 |
| Hamilton, R | 1 |
| Kugler, JD | 1 |
| van Hare, GF | 1 |
| Vetter, V | 1 |
| Vick, GW | 1 |
| De Ferrari, GM | 1 |
| Salvati, P | 1 |
| Grossoni, M | 1 |
| Ukmar, G | 1 |
| Vaga, L | 1 |
| Patrono, C | 1 |
| Peters, RW | 1 |
| Nademanee, K | 1 |
| Veerakul, G | 1 |
| Nimmannit, S | 1 |
| Chaowakul, V | 1 |
| Bhuripanyo, K | 1 |
| Likittanasombat, K | 1 |
| Tunsanga, K | 1 |
| Kuasirikul, S | 1 |
| Malasit, P | 1 |
| Tansupasawadikul, S | 1 |
| Tatsanavivat, P | 1 |
| Shivkumar, K | 1 |
| Schultz, L | 1 |
| Goldstein, S | 1 |
| Gheorghiade, M | 1 |
| Andreotti, F | 1 |
| Kluft, C | 1 |
| Davies, GJ | 1 |
| Huisman, LG | 1 |
| de Bart, AC | 1 |
| Maseri, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Discovering the Genetic Causes of Brugada Syndrome in Thais and Southeast Asian Population[NCT04232787] | 750 participants (Anticipated) | Observational [Patient Registry] | 2016-01-28 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for propranolol and Cardiac Arrest, Sudden
| Article | Year |
|---|---|
Circadian patterns and triggers of sudden cardiac death.
Topics: Adrenergic beta-Antagonists; Circadian Rhythm; Coronary Disease; Death, Sudden, Cardiac; Defibrillat | 1996 |
6 trials available for propranolol and Cardiac Arrest, Sudden
| Article | Year |
|---|---|
β-blockers protect against dispersion of repolarization during exercise in congenital long-QT syndrome type 1.
Topics: Adrenergic beta-Antagonists; Adult; Death, Sudden, Cardiac; Double-Blind Method; Electrocardiography | 2011 |
Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Autonomic Nervous System; Death, Sudden, Cardiac; Female; | 2003 |
Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients > or = 62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction > or = 40%.
Topics: Aged; Aged, 80 and over; Cardiac Complexes, Premature; Death, Sudden, Cardiac; Echocardiography; Ele | 1994 |
Effect of propranolol on circadian variation of myocardial ischemia in elderly patients with heart disease and complex ventricular arrhythmias.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Circadian Rhythm; Death, Sudden, Cardiac; Electrocard | 1995 |
Circadian variation of sudden cardiac death or fatal myocardial infarction is abolished by propranolol in patients with heart disease and complex ventricular arrhythmias.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Circadian Rhythm; Death, Sudden, Cardiac; Female; Hea | 1994 |
Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression.
Topics: Adrenergic beta-Antagonists; Death, Sudden, Cardiac; Double-Blind Method; Electrocardiography; Femal | 1998 |
19 other studies available for propranolol and Cardiac Arrest, Sudden
| Article | Year |
|---|---|
Therapy for triggered acute risk prevention in subjects at increased cardiovascular risk.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aspirin; Death, Sudden, Cardiac; Drug Therapy, | 2013 |
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients.
Topics: Adrenergic beta-Antagonists; Animals; Cardiac Conduction System Disease; Death, Sudden, Cardiac; Dis | 2014 |
To the Editor--Propranolol, a β-adrenoreceptor blocker, prevents arrhythmias also by its sodium channel blocking effect.
Topics: Animals; Death, Sudden, Cardiac; Electrocardiography; Humans; Long QT Syndrome; Propranolol | 2014 |
Reply to the Editor--Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients.
Topics: Animals; Death, Sudden, Cardiac; Electrocardiography; Humans; Long QT Syndrome; Propranolol | 2014 |
Efficacy of different beta-blockers in the treatment of long QT syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Child; Child, Preschool; Death, Sudden, Ca | 2014 |
The potential mechanisms of reduced incidence of ventricular fibrillation as the presenting rhythm in sudden cardiac arrest.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Death, Su | 2009 |
Heart failure: acute ischemic events in HF--should we include sudden death?
Topics: Adrenergic beta-1 Receptor Antagonists; Antihypertensive Agents; Benzopyrans; Death, Sudden, Cardiac | 2011 |
Pharmacological and non-pharmacological management of the congenital long QT syndrome: the rationale.
Topics: Adrenergic beta-Antagonists; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Long QT Sy | 2011 |
Combined sodium and calcium channel blockade in prevention of lethal arrhythmias.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Death, Sudde | 2003 |
An unusual death in an asthmatic patient.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Death, Sudden, Cardiac; Female; Humans; Medication Error | 2003 |
[Arrhythmogenic right ventricular dysplasia/cardiomyopathy - diagnosis in childhood].
Topics: Adolescent; Adult; Age Factors; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; | 2003 |
Propranolol intoxication revealing a Brugada syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Atropine; Bundle-Branch Block; Death, Sudden, Cardiac; Electroca | 2005 |
Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis.
Topics: Acute Disease; Adrenergic Agonists; Adrenergic beta-Antagonists; Amnion; Animals; Arrhythmias, Cardi | 2005 |
Alpha 1-adrenergic blockade and sudden cardiac death.
Topics: Adrenergic alpha-Antagonists; Aminoquinolines; Animals; Arrhythmias, Cardiac; Death, Sudden, Cardiac | 1994 |
Syncope and sudden arrhythmic death complicating pregnancy. A case report of Romano-Ward syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Bradycardia; Cesarean Section; Death, Sudden, Cardiac; Electric | 1993 |
The long QT syndrome in children. An international study of 287 patients.
Topics: Adrenergic beta-Antagonists; Child; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocard | 1993 |
Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction.
Topics: Animals; Autonomic Nervous System; Coronary Circulation; Death, Sudden, Cardiac; Depression, Chemica | 1993 |
Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Asia, Southeastern; Bundle-Branch Block; Death, Sudden, C | 1997 |
Effect of propranolol (long-acting) on the circadian fluctuation of tissue-plasminogen activator and plasminogen activator inhibitor-1.
Topics: Adult; Circadian Rhythm; Death, Sudden, Cardiac; Delayed-Action Preparations; Female; Humans; Incide | 1991 |